2026 Annual Meeting | C3 - Clinical Approach to Muscle Disease: Inflammatory Myopathies and Muscle Pathology

Date Saturday 04/18/26

Time 07:00 AM - 09:00 AM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Elie Naddaf, MD

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should be able to describe the diagnostic approach to patients with suspected myositis; recognize the diagnostic and prognostic values of myositis associated antibodies, and their role in cancer risk stratification; identify the histopathological and electrodiagnostic findings in inflammatory myopathies and their clinical significance; and and review the treatment approach to inflammatory myopathies.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
07:00 AM - 07:05 AM CDT	Speaker	Introduction Elie Naddaf, MD
07:05 AM - 07:30 AM CDT	Speaker	Approach to Patients with Suspected Myositis and Overview of Serological Testing Didem Saygin, MD
07:30 AM - 07:55 AM CDT	Speaker	Introduction to Muscle Biopsy and Electromyography Interpretation Elie Naddaf, MD
07:55 AM - 08:20 AM CDT	Speaker	Treatment Strategies for Idiopathic Inflammatory Myopathies Christopher Mecoli, MD
08:20 AM - 08:50 AM CDT	Discussion	Case-based Discussions Elie Naddaf, MD, Didem Saygin, MD, Christopher Mecoli, MD
08:50 AM - 09:00 AM CDT	Q&A	Questions and Answers Elie Naddaf, MD, Didem Saygin, MD, Christopher Mecoli, MD

Faculty Disclosures
Elie Naddaf, MD	Dr. Naddaf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Expert Connect. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Klick, Inc. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Naddaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arcellx. The institution of Dr. Naddaf has received research support from NIAMS. The institution of Dr. Naddaf has received research support from Fulcrum therapeutics. The institution of Dr. Naddaf has received research support from Abcuro. The institution of Dr. Naddaf has received research support from Cabaletta . The institution of Dr. Naddaf has received research support from Arcellx.
Didem Saygin, MD	The institution of Didem Saygin, MD has received research support from Rheumatology Research Foundation. The institution of Didem Saygin, MD has received research support from C-COMP Pilot Grant (P30). The institution of Didem Saygin, MD has received research support from Rush Pilot Grant.
Christopher Mecoli, MD	Dr. Mecoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Mecoli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Mecoli has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Department of Justice.

��ɫ��

��ɫ��